DeviceTalks Podcast Network

In this special DeviceTalks Weekly Podcast episode, Host Tom Salemi previews the biggest conversations, technologies, and innovators heading to DeviceTalks Boston on May 27–28 at the Boston Convention & Exhibition Center.

First, Tom Salemi and Mike Moore, partner at The Mullings Group, visits with Christian Howell, CEO of Cognito Therapeutics. Howell will be speaking at DeviceTalks Boston about the neuro company’s clinical, fund-raising and partnering success.

Howell also shares insights into Cognito’s partnerships with research institutions and the future of noninvasive therapies for neurodegenerative disease. He’ll be among the many speakers address Innovation & Investment at the conference, with others including the MedTech Innovator Open Rounds sessions and venture capital investors including Abby Hunter-Syed of Olympus Innovation Ventures and Maria Berkman, MD, of Vensana Capital.

Tom and Holly Scott also speak with Dr. Sarah Matt, author of Borderless Healthcare Revolution, about the challenges of connected health adoption and why many health-tech pilots fail to scale. Matt previews her DeviceTalks Boston panel examining the “physician veto” and the barriers device makers face when introducing new digital health technologies into clinical environments.

Several sessions at DeviceTalks Boston will address the challenges and opportunities of Connected Health including a keynote interview with Ashley McEvoy, CEO of Insulet, as well as presentations by Philips, Baxter and others.

The episode also features a wide-ranging conversation with Mullings Group leaders Mike Moore and Holly Scott about the strength of the Massachusetts medtech ecosystem, the growth of surgical robotics, and the importance of conferences in building meaningful industry relationships.

If you want to join us at DeviceTalks Boston, you can register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the price of registration.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:40) - Mike Moore of The Mulling Group and Tom interview Christian Howell, CEO of Cognito Therapeutics
(00:15:40) - Holly Scott of the Mullings Group and Tom interview Sarah Matt, MD, author of The Borderless Healthcare Revolution
(00:22:30) - Holly, Mike and Tom breakdown the components of DeviceTalks Boston and the Massachusetts MedTech industry

In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?

This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.

MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson & Johnson MedTech, and Medtronic.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:00) - Quick recap of DeviceTalks Minnesota
(00:07:05) - MassDevice’s Orthopedic Device Companies Special Report for 2026
(00:08:20) - Masimo shareholders give green light to $10B acquisition by Danaher
(00:09:56) - ResMed enters merger agreement to acquire Noctrix Health for $340 million
(00:14:03) - Johnson & Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery study
(00:15:45) - Medtronic merges Cardiac Surgery, Aortic units into Cardiovascular Surgery business
(00:19:45) - FOMO Studio – Yossi Bar, CEO, LEM Surgical
(00:31:22) - Keynote Interview- Wayne Allen, CEO, Perfuze

In this episode, Host Tom Salemi and Holly Scott, senior partner at The Mullings Group, preview the upcoming DeviceTalks Minnesota agenda. Join us on May 4 at the McNamara Alumni Center!

If you haven’t registered, use the code DTW25 to save 25% off the price of registration, visit https://minnesota.devicetalks.com/.

MassDevice Editor Chris Newmarker also delivers this week’s top newsmakers on the pages of MassDevice—HRS 2026, Johnson & Johnson, Stryker, Medtronic, and Teleflex.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:07:25) - The top cardiac tech stories out of HRS 2026
(00:09:03) - Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse
(00:10:16) - Stryker results miss after Q1 cyberattack; company sticks with guidance
(00:11:43) - Medtronic discloses cybersecurity breach in certain IT systems
(00:15:30) - Teleflex picks Medtronic Coronary & Renal Denervation leader Weidman as new CEO

In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel.

As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO.

This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations.

We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/

Finally, MassDevice Editor Chris Newmarker shares this week’s top newsmakers from MassDevice—Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, and CathWorks.

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:09:23) - 5 next-gen heart valve replacement companies you need to know
(00:11:35) - Abbott completes enrollment in IVL study
(00:13:50) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:15:10) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:17:12) - Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical
(00:23:34) - FOMO Studio: Saul Marquez, CEO, Outcomes Rocket
(00:38:19) - Keynote Conversation: SetPoint Medical CEO Murthy Simhambhatla

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Michael Carter, SVP, President, Cranial & Spinal Technologies about the company’s deployment of robotics, AI and other tech.

Managing Editor Kayleen Brown hosts Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru, on this weeks’ FOMO.

MassDevice Editor Chris Newmarker highlights the MassDevice newsmakers – Stereotaxis, Robocath, Prosomnus, Johnson & Johnson MedTech, Avanos Medical, Stryker and Amplitude Vascular Systems.

Thanks to Greenlight Guru for sitting in our FOMO studio! Download its QMSR readiness playbook, it's everything you need to get compliant with QMSR, all in one place:
https://www.greenlight.guru/qmsr-readiness-playbook-free-download

If you haven’t registered for DeviceTalks Minnesota or DeviceTalks Boston, use the code DTW25 to save 25%

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe 

Chapters

(00:01:25) - Discount Code for DeviceTalks events
(00:03:11) - MassDevices' Newmarker's Newsmakers
(00:05:25) - Stereotaxis to acquire Robocath for up to $45M
(00:09:02) - ProSomnus gets FDA nod for latest sleep apnea therapy device
(00:12:08) - - Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%
(00:15:11) - Avanos Medical agrees to be acquired by private equity firm in $1.3B deal
(00:16:22) - Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
(00:18:06) - FOMO Guest: Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru
(00:31:55) - Keynote Interview- Michael Carter, SVP President, Cranial & Spinal Technologies, Medtronic